Stamford Pharmaceuticals is Drug Discovery in United States that focus on small molecule business. Founded in 1995. They cover business area such as provider, clinical-stage immuno-oncology treatment, medicine, primary, recurrent and metastatic cancer, a number, different technology, approach, viral vector, affinity agent, biological, small molecule immune modulator, kinase inhibitor, chemotherapeutic, doctor, new and advanced treatment, patient, advanced stage.
1995
( 29 years old in 2024 )
Small Molecule
-
Houston, TX
United States
Private
providerclinical-stage immuno-oncology treatmentmedicineprimary, recurrent and metastatic cancera numberdifferent technologyapproachviral vectoraffinity agentbiologicalsmall molecule immune modulatorkinase inhibitorchemotherapeuticdoctornew and advanced treatmentpatientadvanced stage
* We use standard office opening hours in near Stamford Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Stamford Pharmaceuticals is Drug Discovery business from United States that founded in 1995 (29 years old in 2024), Stamford Pharmaceuticals business is focusing on Small Molecule.
Stamford Pharmaceuticals headquarter office and corporate office address is located in Houston, TX United States.
Stamford Pharmaceuticals was founded in United States.
In 2024, Stamford Pharmaceuticals is currently focus on small molecule sector.
Above is snippet of Google Trends for "small molecule" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Stamford Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
